Not applicableStudy completedNCT03305380
What this trial is testing
Radiomics to Identify Patients at Risk for Developing Pneumonitis, Differentiate Immune Checkpoint Inhibitor-induced Pneumonitis From Other Lung Inflammation and Distinguish Tumour Pseudo-progression From Real Tumour Growth
Who this might be right for
Stage IV Non-small Cell Lung Cancer
Maastricht Radiation Oncology 637